Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced immunocytopenia].

A Salama1, C Mueller-Eckhardt

  • 1Zentrum für Innere Medizin, Universität Giessen.

Immunitat Und Infektion
|April 1, 1989
PubMed
Summary

Drug-induced immunocytopenias, affecting red blood cells, platelets, or granulocytes, are caused by drug-dependent antibodies. These antibodies can form through stable drug conjugation or loose drug-cell interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclooxygenase-2 expression as a prognostic factor in pediatric classical Hodgkin lymphoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Malignant renal obstruction without dilatation.

Acute medicine·2019
Same author

Efficacy and safety of a new intravenous immunoglobulin (Panzyga<sup>®</sup> ) in chronic immune thrombocytopenia.

Transfusion medicine (Oxford, England)·2019
Same author

IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.

British journal of biomedical science·2018
Same author

Improvement of the developmental competence of canine oocyte using caffeine supplementation during IVM at different maturation time.

Zygote (Cambridge, England)·2018
Same author

Distinct recovery of copper and aluminum from waste electric wires using a roll-type electrostatic separator.

Waste management (New York, N.Y.)·2018

Area of Science:

  • Immunology
  • Hematology
  • Pharmacology

Context:

  • Drug-induced immunocytopenias account for 10-20% of immune hemolytic anemias, immune thrombocytopenias, and immune granulocytopenias.
  • While typically affecting a single cell type, simultaneous involvement of two cell types can occur.
  • Onset can be rapid (minutes to hours) or gradual (days to weeks).

Purpose:

  • To elucidate the mechanisms underlying drug-dependent antibody formation in immunocytopenias.
  • To differentiate between complement-activating and non-complement-activating antibody responses.
  • To explore the immunogenic potential of drugs and their metabolites.

Summary:

  • Drug-dependent antibodies are implicated in 10-20% of immunocytopenias.
  • Antibody reactions can be rapid, involving complement-activating IgG/IgM, or gradual, involving non-complement-activating IgG.
  • Antigens may be drug-cell membrane complexes or autoantibodies, with immunogenicity arising from stable conjugation or loose drug-cell interactions.

Impact:

  • Provides insights into the pathogenesis of drug-induced blood cell destruction.
  • Highlights the diverse mechanisms of antibody formation in response to drugs.
  • Informs diagnostic approaches and potential therapeutic strategies for drug-induced immunocytopenias.

Related Experiment Videos